Gene · 8239
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Multifaceted Approaches Combining Low or High LET Radiation and Pharmacological Interventions in Cancer and Radioprotection: From Bench to Bedside. | Front Oncol | 2022 | 35419286 | PubTator, text mining | PubMed |
| The role of ubiquitination and deubiquitination in tumor invasion and metastasis. | Int J Biol Sci | 2022 | 35414786 | PubTator, text mining | PubMed |
| IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myeloma. | Int J Biol Sci | 2022 | 35414773 | PubTator, text mining | PubMed |
| Atypical Ubiquitination and Parkinson's Disease. | Int J Mol Sci | 2022 | 35409068 | PubTator, text mining | PubMed |
| Recycling and Reshaping-E3 Ligases and DUBs in the Initiation of T Cell Receptor-Mediated Signaling and Response. | Int J Mol Sci | 2022 | 35408787 | PubTator, text mining | PubMed |
| Modulating the Ubiquitin-Proteasome System: A Therapeutic Strategy for Autoimmune Diseases. | Cells | 2022 | 35406655 | PubTator, text mining | PubMed |
| The Effect of the NFκB-USP9X-Cx43 Axis on the Dynamic Balance of Bone Formation/Degradation during Ossification of the Posterior Longitudinal Ligament of the Cervical Spine. | Oxid Med Cell Longev | 2022 | 35391932 | PubTator, text mining | PubMed |
| Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | Cell Mol Gastroenterol Hepatol | 2022 | 35390516 | PubTator, text mining | PubMed |
| Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis. | J Clin Invest | 2022 | 35389885 | PubTator, text mining | PubMed |
| CRIA: An Interactive Gene Selection Algorithm for Cancers Prediction Based on Copy Number Variations. | Front Plant Sci | 2022 | 35386679 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| A positive feedback loop between LINC01605 and NF-κB pathway promotes tumor growth in nasopharyngeal carcinoma. | RNA Biol | 2022 | 35373703 | PubTator, text mining | PubMed |
| Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex. | J Clin Invest | 2022 | 35358092 | PubTator, text mining | PubMed |
| Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease. | Front Cardiovasc Med | 2022 | 35355968 | PubTator, text mining | PubMed |
| Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives. | Biosci Rep | 2022 | 35352805 | PubTator, text mining | PubMed |
| Contribution of proteases to the hallmarks of aging and to age-related neurodegeneration. | Aging Cell | 2022 | 35349763 | PubTator, text mining | PubMed |
| MCL-1 is a clinically targetable vulnerability in breast cancer. | Cell Cycle | 2022 | 35349392 | PubTator, text mining | PubMed |
| Clinical significance of FBXW7 loss of function in human cancers. | Mol Cancer | 2022 | 35346215 | PubTator, text mining | PubMed |
| Diagnostic performance of automated, streamlined, daily updated exome analysis in patients with neurodevelopmental delay. | Mol Med | 2022 | 35346031 | PubTator, text mining | PubMed |
| Indirubin-3'-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma. | EBioMedicine | 2022 | 35344764 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8239/papers?page=25